For the year ending 2025-12-31, SNGX had $116,639 increase in cash & cash equivalents over the period. -$10,272,436 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -11,080,380 |
| Amortization and depreciation | 3,224 |
| Non-cash lease expense | 114,602 |
| Share-based compensation | 587,583 |
| Issuance of common stock to vendors for services | 76,600 |
| Prepaid expenses and other current assets | -10,958 |
| Operating lease liability | -114,322 |
| Accounts payable and accrued expenses | -16,501 |
| Accrued compensation | 151,683 |
| Net cash flows from operating activities | -10,266,553 |
| Purchases of furniture and equipment | 5,883 |
| Net cash flows from investing activities | -5,883 |
| Proceeds from issuance of common stock pursuant to at market issuance sales agreement | 4,666,421 |
| Proceeds from issuance of common stock and pre-funded warrants | 7,498,522 |
| Stock issuance costs associated | 708,236 |
| Proceeds from the exercise of warrants | 305,241 |
| Convertible debt repayments | 1,372,873 |
| Net cash flows from financing activities | 10,389,075 |
| Net increase (decrease) in cash and cash equivalents | 116,639 |
| Cash and cash equivalents at beginning of year | 7,819,514 |
| Cash and cash equivalents at end of year | 7,936,153 |
SOLIGENIX, INC. (SNGX)
SOLIGENIX, INC. (SNGX)